Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Xcelerate Inc (OP: XCRT )

0.0169 -0.0030 (-15.08%)
Streaming Delayed Price Updated: 3:57 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Xcelerate Inc

< Previous 1 2 Next >
Xcelerate, Inc. Announces Funding
Via ACCESSWIRE
Xcelerate, Inc. Announces the Launch of the Ceramedx Tik Tok Skincare Campaign
Via ACCESSWIRE
Xcelerate, Inc. Issues Shareholder Update
Via ACCESSWIRE
Xcelerate, Inc. Announces Commencement of the Nationalization Process for its PCT International Patent Applications
Via ACCESSWIRE
Xcelerate, Inc. Releases Shareholder Update
Via ACCESSWIRE
Xcelerate, Inc. Retains Investment Bank Craft Capital Management to Provide Investment Banking and Up-Listing Advisory Services
Via ACCESSWIRE
Xcelerate Announces Marketing Agreement
Via ACCESSWIRE
Xcelerate Announces that Afya Sasa Signs Agreement with the National Hospital of Tanzania
Via ACCESSWIRE
Fabian Urquijo Joins the Advisory Board of Xcelerate, Inc.
Via ACCESSWIRE
Harbinger Research Issues Correction Notice for Research Report issued today pertaining to Xcelerate, Inc. (OTCQB: XCRT)
Via ACCESSWIRE
Xcelerate, Inc. Addresses Concerns About Recently Released Research Report
Via ACCESSWIRE
Harbinger Research Publishes Coverage Initiation Report on Xcelerate, Inc., a Rapidly Growing Medical AI Technology, Healthcare Services, and Skin Care Products Company
Via ACCESSWIRE
Xcelerate, Inc. Announces Change of Auditors
Via ACCESSWIRE
Xcelerate, Inc. Announces That It Has Filed Its 2023 Annual Report
Via ACCESSWIRE
Xcelerate, Inc. Announces That ESN Group, Inc. Has Gone Live on the Army & Air Force Exchange Service Online Exchange
Via ACCESSWIRE
Xcelerate Inc. to Acquire Controlling Interest in ESN Group, Inc
Via ACCESSWIRE
Xcelerate, Inc. Releases Message from CEO
Via ACCESSWIRE
Xcelerate, Inc. to Develop Consumer Healthcare Products
Via ACCESSWIRE
Xcelerate, Inc. Engages Leading Investor Relations Firm Darrow Associates to Enhance Capital Markets Presence
Via ACCESSWIRE
Xcelerate, Inc. Announces Publication of its Two Utility Patent Applications
Via ACCESSWIRE
Xcelerate, Inc. Announces that ESN Group, Inc. Has Been Approved as a Vendor to Army & Air Force Exchange Service
Via ACCESSWIRE
Xcelerate, Inc. Acquires a Majority Interest in ESN Group
Via ACCESSWIRE
Xcelerate, Inc. Announces Interview With CEO Michael O'Shea
Via ACCESSWIRE
Additional Countries Add Patent Protection
Via ACCESSWIRE
Xcelerate, Inc. Announces PTO and PCT Filings For Surgical Devices
Via ACCESSWIRE
Xcelerate, Inc. Announces Agreement to Acquire a Controlling Interest in ESN, Inc.
Via ACCESSWIRE
Xcelerate, Inc. Announces Uplisting to OTCQB Market
Via ACCESSWIRE
Xcelerate, Inc. Applies to Trade on the OTCQB Venture Marketplace
MAULDIN, SC / ACCESSWIRE / June 22, 2022 / Xcelerate, Inc. (OTC PINK:XCRT) today announced that it has initiated its plan to upgrade the trading of its common stock from the OTC Pink Market to the... 
From Xcelerate, Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Cathy Scangarella to Join the Advisory Board of Xcelerate, Inc.
MAULDIN, SC / ACCESSWIRE / June 7, 2022 / Xcelerate, Inc. (OTC PINK:XCRT) today announced that Cathy Scangarella has accepted an invitation to join its Advisory Board effective immediately. 
From Xcelerate, Inc.
Via AccessWire
Xcelerate, Inc. Announces Appointment of New Board Member
MAULDIN, SC / ACCESSWIRE / May 11, 2022 / Xcelerate, Inc. (OTC PINK:XCRT) recently announced that it had signed a purchase agreement to acquire a portfolio of patents, patents pending and technology... 
From Xcelerate, Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.